Due to technical maintenance the webshop is closed until January 2th, 2023. We wish you a successful 2023!
FEBRUARY 15, 2018, DANVERS, MA – Cell Signaling Technology, Inc. (CST), a leading provider of antibodies, kits, and services, is honored with the 2018 CiteAb Award for “Antibody Company of the Year” and “Antibody Company Succeeding in Cancer Biology.” CST was also highly commended for the “Chemical Probes Supplier to Watch” and “Antibody Company with Sustained Success in China.” The CiteAb Antibody Awards aim to celebrate the very best suppliers, reagents, and individuals in the research antibody sector, recognizing the efforts that are made to progress science.
Dr. Andrew Chalmers, Founder of CiteAb, said: “This is an esteemed award that recognizes CST as the most successful antibody company based on our data from CiteAb. This is no small feat and a direct result of the company offering a large number of products that help researchers make novel findings. This would not have been possible without a huge amount of effort from everybody at CST. We wholeheartedly congratulate CST on their achievements.”
“Being scientists ourselves, we are truly passionate about scientific discovery. We are honored to be recognized as Antibody Company of the year for having the most antibody life science research citations during 2017. Equally as gratifying is the way in which our antibody products are enabling cancer researchers, as the company having the most citations achieved in the cancer biology research field in 2017. All of us at CST are driven to support researchers, so they can discover faster and more frequently to enable a better future for healthcare,” said Michael J. Comb, Cell Signaling Technology President, and CEO.